where X means methine group or nitrogen atom; B means the group NR3R4; each of R1,R2,R3,R4 means independently hydrogen atom, alkyl with 1-8 carbon atoms or residue Ar, or the group (A) , and their pharmaceutically acceptable salts. Invention relates to also a pharmaceutical composition comprising at least one pharmaceutical carrier and a compound of the formula (I) as an active substance or its a pharmaceutically acceptable salt taken in effective amount and to a method of inhibition of cellular proliferation induced by protein tyrosine kinase by administration of a compound of the formula (I) in effective dose or its pharmaceutically acceptable salt in effective dose. EFFECT: new compounds indicated above, valuable medicinal properties. 46 cl, 2 tbl, 131 ex"/> DERIVATIVES OF 6-ARYLPYRIDO2,3-DPYRIMIDINES AND -NAPHTHYRIDINES, PHARMACEUTICAL COMPOSITION SHOWING INHIBITORY EFFECT ON CELLULAR PROLIFERATION INDUCED BY PROTEIN TYROSINE KINASE AND METHOD OF INHIBITION OF CELLULAR PROLIFERATION
首页> 外国专利> DERIVATIVES OF 6-ARYLPYRIDO2,3-DPYRIMIDINES AND -NAPHTHYRIDINES, PHARMACEUTICAL COMPOSITION SHOWING INHIBITORY EFFECT ON CELLULAR PROLIFERATION INDUCED BY PROTEIN TYROSINE KINASE AND METHOD OF INHIBITION OF CELLULAR PROLIFERATION

DERIVATIVES OF 6-ARYLPYRIDO2,3-DPYRIMIDINES AND -NAPHTHYRIDINES, PHARMACEUTICAL COMPOSITION SHOWING INHIBITORY EFFECT ON CELLULAR PROLIFERATION INDUCED BY PROTEIN TYROSINE KINASE AND METHOD OF INHIBITION OF CELLULAR PROLIFERATION

机译:6-芳基[2,3-D]嘧啶和-萘啶的衍生物,药物成分对蛋白质酪氨酸激酶诱导的细胞增殖的抑制作用及抑制细胞增殖的方法

摘要

FIELD: organic chemistry, heterocyclic compounds, biochemistry, pharmacy. SUBSTANCE: invention relates to novel derivatives of 6-arylpyrido[2,3-d]pyrimidine and naphthyridine, their pharmaceutically acceptable salts, a pharmaceutical composition showing an inhibitory effect on cellular proliferation induced by protein tyrosine kinase and a method of inhibition of cellular proliferation. Indicated properties of compounds will ensure to use their in the important biological processes in pathological mechanism and proliferative diseases, for example, cancer, atherosclerosis and restenosis. The proposed compounds correspond to the general formula (I) where X means methine group or nitrogen atom; B means the group NR3R4; each of R1,R2,R3,R4 means independently hydrogen atom, alkyl with 1-8 carbon atoms or residue Ar, or the group (A) , and their pharmaceutically acceptable salts. Invention relates to also a pharmaceutical composition comprising at least one pharmaceutical carrier and a compound of the formula (I) as an active substance or its a pharmaceutically acceptable salt taken in effective amount and to a method of inhibition of cellular proliferation induced by protein tyrosine kinase by administration of a compound of the formula (I) in effective dose or its pharmaceutically acceptable salt in effective dose. EFFECT: new compounds indicated above, valuable medicinal properties. 46 cl, 2 tbl, 131 ex
机译:领域:有机化学,杂环化合物,生物化学,药学。发明内容本发明涉及6-芳基吡啶并[2,3-d]嘧啶和萘啶的新型衍生物,其药学上可接受的盐,对蛋白酪氨酸激酶诱导的细胞增殖具有抑制作用的药物组合物以及抑制细胞增殖的方法。化合物的指示性质将确保将其用于重要的生物过程中的病理机制和增生性疾病,例如癌症,动脉粥样硬化和再狭窄。拟议的化合物对应于通式(I),其中X表示次甲基或氮原子; B表示基团NR 3 R 4 ; R 1 ,R 2 ,R 3 ,R 4 中的每一个独立地表示氢原子,具有1-的烷基8个碳原子或残基Ar或基团(A)及其药学上可接受的盐。本发明还涉及以有效量包含至少一种药物载体和式(I)化合物作为活性物质或其药学上可接受的盐的药物组合物,并且涉及一种抑制由蛋白酪氨酸激酶诱导的细胞增殖的方法。通过以有效剂量施用式(I)化合物或其药学上可接受的盐。功效:以上指出的新化合物,有价值的药用特性。 46 cl,2汤匙,131前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号